Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Phillips

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Lancet (London, England)|September 27, 2008
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic reviewBradley M Mathers, Louisa Degenhardt, Benjamin Phillips, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Procalcitonin Values Fail to Track the Presence of Secondary Bacterial Infections in COVID-19 ICU PatientsElsa Harte, Sharuha Kumarasamysarma, Benjamin Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN AlterationsUrsula Grazini, Aleksandra Markovets, Lucy Ireland, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 19, 2010
Factors associated with survival following blunt chest trauma in older patients: results from a large regional trauma cooperativeDavid T Harrington, Benjamin Phillips, Jason Machan, et al.
Nature Communications|April 22, 2025
The Sex Inclusive Research Framework to address sex bias in preclinical research proposalsNatasha A Karp, Manuel Berdoy, Kelly Gray, et al.
Cell Reports. Medicine|August 26, 2025
AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertionsAisha M Swaih, Sara Talbot, Adriana Savoca, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Lancet (London, England)|September 27, 2008
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic reviewBradley M Mathers, Louisa Degenhardt, Benjamin Phillips, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Procalcitonin Values Fail to Track the Presence of Secondary Bacterial Infections in COVID-19 ICU PatientsElsa Harte, Sharuha Kumarasamysarma, Benjamin Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN AlterationsUrsula Grazini, Aleksandra Markovets, Lucy Ireland, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 19, 2010
Factors associated with survival following blunt chest trauma in older patients: results from a large regional trauma cooperativeDavid T Harrington, Benjamin Phillips, Jason Machan, et al.
Nature Communications|April 22, 2025
The Sex Inclusive Research Framework to address sex bias in preclinical research proposalsNatasha A Karp, Manuel Berdoy, Kelly Gray, et al.
Cell Reports. Medicine|August 26, 2025
AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertionsAisha M Swaih, Sara Talbot, Adriana Savoca, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Pageof 4